Alphatec Holdings, Inc. ATEC
We take great care to ensure that the data presented and summarized in this overview for Alphatec Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ATEC
View all-
Black Rock Inc. New York, NY8.29MShares$82.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.92MShares$58.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.43MShares$44 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.39MShares$43.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.04MShares$40.1 Million0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$39.8 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.65MShares$36.3 Million0.01% of portfolio
-
State Street Corp Boston, MA3.14MShares$31.2 Million0.0% of portfolio
-
Bnp Paribas Asset Management Holding S.A.2.93MShares$29.1 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA2.36MShares$23.5 Million0.0% of portfolio
Latest Institutional Activity in ATEC
Top Purchases
Top Sells
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Insider Transactions at ATEC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 23
2024
|
Evan Bakst |
BUY
Open market or private purchase
|
Indirect |
35,000
+41.18%
|
$175,000
$5.76 P/Share
|
Aug 23
2024
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
16,978
+4.87%
|
$84,890
$5.89 P/Share
|
Aug 22
2024
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
8,818
+2.73%
|
$44,090
$5.67 P/Share
|
Aug 21
2024
|
David M Demski |
BUY
Open market or private purchase
|
Direct |
50,000
+14.77%
|
$250,000
$5.67 P/Share
|
Aug 06
2024
|
Scott Lish CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
71,500
+5.76%
|
$214,500
$3.02 P/Share
|
Aug 02
2024
|
Keith Valentine |
BUY
Open market or private purchase
|
Direct |
39,000
+32.19%
|
$234,000
$6.55 P/Share
|
Aug 02
2024
|
David M Demski |
BUY
Open market or private purchase
|
Direct |
40,000
+14.37%
|
$240,000
$6.56 P/Share
|
Jul 29
2024
|
Keith Valentine |
BUY
Grant, award, or other acquisition
|
Direct |
43,140
+44.71%
|
-
|
Jun 12
2024
|
Tyson Eliot Marshall GENERAL COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
50,232
-16.98%
|
$502,320
$10.88 P/Share
|
Jun 12
2024
|
Jeffrey P Rydin |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+2.85%
|
-
|
Jun 12
2024
|
Evan Bakst |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+1.49%
|
-
|
Jun 12
2024
|
Karen K Mcginnis |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+14.87%
|
-
|
Jun 12
2024
|
Quentin S. Blackford |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+2.76%
|
-
|
Jun 12
2024
|
David R Pelizzon |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+5.19%
|
-
|
Jun 12
2024
|
David M Demski |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+7.78%
|
-
|
Jun 12
2024
|
Ward W Woods Jr |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+10.74%
|
-
|
Jun 12
2024
|
Mortimer Berkowitz Iii |
BUY
Grant, award, or other acquisition
|
Direct |
16,747
+2.46%
|
-
|
Apr 24
2024
|
John Todd Koning CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
37,500
-8.7%
|
$450,000
$12.82 P/Share
|
Mar 14
2024
|
Evan Bakst |
BUY
Open market or private purchase
|
Indirect |
15,000
+50.0%
|
$195,000
$13.53 P/Share
|
Mar 07
2024
|
Quentin S. Blackford |
BUY
Open market or private purchase
|
Direct |
20,000
+3.37%
|
$240,000
$12.83 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.38M shares |
---|---|
Open market or private purchase | 225K shares |
Exercise of conversion of derivative security | 71.5K shares |
Open market or private sale | 551K shares |
---|---|
Payment of exercise price or tax liability | 364K shares |